Alembic Pharmaceuticals LimitedNSE: APLLTD

Press Release Jul 26 2025

· Issued by Alembic Pharmaceuticals Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-jul-26-2025-6

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated July 26, 2025, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Carbamazepine Extended-Release Tablets USP, 100 mg, 200 mg, and 400 mg".

View Attachment

6ix hasn’t read this filing yet.

Alembic Pharmaceuticals Limited on 6ix

Earlier from Alembic Pharmaceuticals

Later from Alembic Pharmaceuticals

All Alembic Pharmaceuticals news releases